We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$640M
Cap. Flow
+$72.3M
Cap. Flow %
0.39%
Top 10 Hldgs %
10.88%
Holding
2,903
New
146
Increased
740
Reduced
905
Closed
305

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$81.7M
2
BA icon
Boeing
BA
+$67.3M
3
ATVI
Activision Blizzard
ATVI
+$59.4M
4
UNH icon
UnitedHealth
UNH
+$58.1M
5
SYY icon
Sysco
SYY
+$47.3M

Top Sells

Rank Stock Value
1
KR icon
Kroger
KR
+$88.6M
2
WAB icon
Wabtec
WAB
+$57.7M
3
LUV icon
Southwest Airlines
LUV
+$57.2M
4
HON icon
Honeywell
HON
+$56.3M
5
ORLY icon
O'Reilly Automotive
ORLY
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Financials 14.04%
3 Healthcare 12.9%
4 Industrials 11.58%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORE
1301
DELISTED
Core Mark Holding Co., Inc.
CORE
$73K ﹤0.01%
1,716
CSRA
1302
DELISTED
CSRA Inc.
CSRA
$73K ﹤0.01%
2,300
BNDX icon
1303
Vanguard Total International Bond ETF
BNDX
$82.2B
$72K ﹤0.01%
1,332
CHT icon
1304
Chunghwa Telecom
CHT
$33.4B
$72K ﹤0.01%
2,306
CLB icon
1305
Core Laboratories
CLB
$521M
$72K ﹤0.01%
600
VRSK icon
1306
Verisk Analytics
VRSK
$27.2B
$72K ﹤0.01%
900
VRTX icon
1307
Vertex Pharmaceuticals
VRTX
$122B
$72K ﹤0.01%
997
-7
-0.7% -$570
RAD
1308
DELISTED
Rite Aid Corporation
RAD
$72K ﹤0.01%
443
CIM
1309
Chimera Investment
CIM
$1.05B
$71K ﹤0.01%
1,405
MNST icon
1310
Monster Beverage
MNST
$93.2B
$71K ﹤0.01%
3,246
-606
-16% -$13.9K
ETW
1311
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
$70K ﹤0.01%
6,995
LGND icon
1312
Ligand Pharmaceuticals
LGND
$5.97B
$70K ﹤0.01%
1,119
MFIC icon
1313
MidCap Financial Investment
MFIC
$791M
$70K ﹤0.01%
4,000
HSEA.CL
1314
DELISTED
HSBC Holdings plc
HSEA.CL
$70K ﹤0.01%
2,708
WWAV
1315
DELISTED
The WhiteWave Foods Company
WWAV
$70K ﹤0.01%
1,270
-21
-2% -$1.15K
PFF icon
1316
iShares Preferred and Income Securities ETF
PFF
$13.2B
$69K ﹤0.01%
1,865
-3,925
-68% -$149K
ACC
1317
DELISTED
American Campus Communities, Inc.
ACC
$69K ﹤0.01%
1,400
-136
-9% -$6.56K
ISBC
1318
DELISTED
Investors Bancorp, Inc.
ISBC
$69K ﹤0.01%
5,000
CENX icon
1319
Century Aluminum
CENX
$4.47B
$68K ﹤0.01%
+8,000
New +$68.4K
CWI icon
1320
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.74B
$68K ﹤0.01%
3,320
VASC
1321
DELISTED
Vascular Solutions Inc
VASC
$68K ﹤0.01%
1,219
-150
-11% -$7.64K
UA icon
1322
Under Armour Class C
UA
$2.96B
$67K ﹤0.01%
2,729
-503
-16% -$13.9K
ABCO
1323
DELISTED
Advisory Board Co
ABCO
$67K ﹤0.01%
2,047
-23
-1% -$850
PEI
1324
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$67K ﹤0.01%
236
BBL
1325
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$67K ﹤0.01%
+2,130
New +$67.7K

Similar funds

Glenmede Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Glenmede Trust held 2,903 positions worth $18.4B, up 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust's Q4 2016 filing shows 146 new, 740 increased, 905 reduced and 305 closed positions. Its largest new stake was CACI: 324,090 shares worth $40.3M. The largest sale was Kroger, an estimated $88.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2016 buy was CACI: 324,090 shares worth $40.3M.
  • Glenmede Trust added most to Trane Technologies in Q4 2016, an estimated $81.7M increase.
  • Glenmede Trust's biggest Q4 2016 reduction was Kroger, cutting an estimated $88.6M.
  • Glenmede Trust fully exited Tutor Perini Cor in Q4 2016, selling an estimated $7.9M.
  • Glenmede Trust's ten largest holdings make up 11% of its $18.4B portfolio in Q4 2016.
  • Glenmede Trust opened 146 new positions and closed 305 in Q4 2016.
  • Glenmede Trust's portfolio value rose 3.6% quarter-over-quarter to $18.4B.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.